expense and income tax expense rose slightly, by Baht 78 million or 0.33 percent over-quarter, as a result of an increase of Baht 450 million or 2.90 percent in non-interest income, and an increase of Baht
economic policy. But, the global economy trend as continued to improve. Thai economy is growing as slowly which the tourism and exports were driving force in past time. Including, the income and unemployment
of sales and services 2,060.70 2,208.18 1,283.13 60.60% (6.68%) 4,268.88 2,602.14 64.05% Gross profit 46.01 143.22 121.17 (62.03%) (67.87%) 189.23 257.41 (26.49%) Other income 0.61 2.61 1.40 (56.43
40.5 (110.2) (150.7) N.A. 53.5 (24.4) (77.9) N.A. N.A.(
(decreased) 2018 2017 Amount % Total revenues 820.40 815.31 5.09 0.62 Total expenses and finance cost 799.70 782.71 16.99 2.17 Share of profit from investments in associated companies 84.23 10.55 73..68 698.45
- Translation- June 11, 2019 Subject: Notification the Acquisition of share of BS Myco Biotech Company Limited. (Additional Information Memorandum Concerning the Acquisition of Assets) To: Director and Manager
YOY 9M/2020 9M/2019 YOY Service revenue 905.64 590.71 53.31% 2,588.84 1,609.44 60.85% Gross profit 164.54 98.70 66.71% 433.60 252.42 71.78% Other income 10.75 - 100.00% 17.57 9.84 78.56% Expenses of
will be recorded as unearned income in S’s consolidated financial statement and recognized as revenue over 30 years start in Q1’2019. In the meantime, S has invested in 20% shareholding in SPRIME
Depository Receipt Representing Foreign Securities IPO P.S.P. SPECIALTIES PUBLIC COMPANY LIMITED / P.S.P. SPECIALTIES PUBLIC COMPANY LIMITED Common share IPO PRIMO SERVICE SOLUTIONS PUBLIC
previous year which a net loss of Baht 9.99 million, the loss decrease Baht 1.54 million or decrease by 15.36% , the main reasons are as follow 1. Revenue from sale , Other income The company had revenue